Select a Region North America

Expertise

Joe Bachstadt

Vice President Patient Services Affordability

专长:

Affordability Programs (PAP, Copay), Hub & Adherence Solutions, Managed Care, Managed Markets, Market Access, Oncology, Patient Services, Pricing, Reimbursement & Market Access, Product Launch, Regulatory Compliance

As a leader for EVERSANA’s patient services, Joe is helping partners move past access barriers with custom affordability solutions that focus on securing treatments for patients and managing costs. Joe’s 15 years of experience leading patient services programs has developed him into an expert on program integration; managing co-pay and voucher programs; managing free goods and bridge programs; fraud, waste and abuse detection; digital program integrations; and advanced analytics and reporting. He also specializes in vaccine and oncology access and reimbursement.

Joe holds a bachelor’s degree in biology from the University of Delaware.

Articles by Joe Bachstadt

Brand Planning – Fitting Financial and Copay Services into Existing Models

EVERSANA’s Kevin O’Meara, Vice President, Patient Services Solutions, Joe Bachstadt, Vice President, Patient Services Affordability, and Chris Lagoerio, Director, Revenue Management, presented a session, “Brand Planning – Fitting Financial and Copay Services into Existing Models,” at Informa Connect’s Copay, Reimbursement and Access Congress. Session Summary Since the early 2000s copay programs have evolved, becoming increasingly […]

WEBINAR: Industry Disruptors — Stay on the Pulse of Trends in Co-pay Exclusions, Accumulators and Maximizers

In changing market conditions, the need for comprehensive patient data and “just right” affordability programs calls for a sophisticated new model that can alleviate patients’ financial burden and drive therapy adoption. When barriers to access exist, our targeted affordability solutions – co-pay programs, patient assistance programs and alternative payment solutions – help your patients secure treatments and […]

The Patient Access Paradox: How the New CMS Rule Could Prioritize Drug Pricing Before Clinical Decision-Making

In January 2023, co-pay programs will be put to the test, consequently examining how well your brand can adapt to the Final Rule changes to meet patient and provider needs. Our recommendation: Don’t wait – start solutioning a patient-centric approach to access and affordability now.

Interested in scheduling a meeting or speaking event?

联系我们

  • 这个字段是用于验证目的,应该保持不变。